Pharmaceutical Sciences
Research Agricultural
Total number of Record(s): 127
शीर्षक | मुख्य जाँचकर्ता | शुरुवाती साल | निधीयन एजेंसी | ध्यानाकर्षण क्षेत्र |
---|---|---|---|---|
Neutralizing Peptide Antibody Designed for Human Complement Fragment 5a (hC5a) | Dr Soumendra Rana, Assistant Professor, Indian Institute of Technology (IIT) Bhubaneswar | 2020 | Drug repurposing for COVID-19 | |
Development of affordable synthetic route of Re-purposed small molecule drugs for the treatment of SARS-CoV-2 | Dr Parthasarathi Das, Associate Professor, Dr Somnath Yadav, Assistant Professor, Dr Soumitra Maity, Assistant Professor, Indian Institute of Technology (IIT), Dhanbad | 2020 | Drug repurposing for COVID-19 | |
Developing a novel effective therapeutic agent targeting pancreatic Cancer | Dr Ramesh Ummanni, Scientist, CSIR-Indian Institute of Chemical Technology (CSIR-IICT), Hyderabad | 2020 | Council of Scientific and Industrial Research (CSIR), Government of India | New molecule development against pancreatic cancer |
Preparation of Disease management Manual for Primary Health Centers (PHCs) and Hospitals | Prof Satadal Saha, Indian Institute of Technology (IIT) Kharagpur, Prof Dipankar Bandyopadhyay, Indian Institute of Technology (IIT) Guwahati | 2020 | Management of Primary Health Centres | |
Identification of a Potential Peptide Inhibitor of SARS-CoV-2 Targeting its Entry into the Host Cells | Dr Mirza S Baig, Associate Professor, Indian Institute of Technology (IIT) Indore | 2020 | Drug repurposing for COVID-19 | |
Development of vapour phase catalytic ammoxidation processes for the synthesis of aromatic nitriles | Dr N. Lingiah, Scientist, CSIR-Indian Institute of Chemical Technology (CSIR-IICT), Hyderabad | 2020 | Council of Scientific and Industrial Research (CSIR), Government of India | Agrochemicals & Pharmaceuticals |
A Novel First AId Technique for Treating COVID-19 | Prof M Manivannan, Professor, Indian Institute of Technology (IIT) Madras | 2020 | Technique for Treating COVID-19 | |
Virtual Screening and in vitro validation of SARS CoV-II Main Protease inhibitors | Dr Sharad Gupta, Associate Professor, Dr Mithun Radhakrishna, Assistant Professor, Indian Institute of Technology (IIT) Gandhinagar | 2020 | Drug repurposing for COVID-19 | |
Development of Monitoring and Evaluation protocol for accelerated MDA (Mass Drug Administration) with IDA (Ivermectin, Diethylcarbamazine and Albendazole) for lymphatic filariasis elimination programme | Dr Jambulingam P, Director, Vector Control Research Centre (ICMR-VCRC), Puducherry | 2019 | Bill & Melinda Gates Foundation (BMGF), USA | Filariasis; Biostatistics |
Target identification and hit-to-lead optimization of SRI-12742 targeting MDR A baumannii | Dr Sidharth Chopra, Scientist, Central Drug Research Institute (CSIR-CDRI), Uttar Pradesh | 2019 | Indian Council of Medical Research (ICMR), New Delhi - German Federal Ministry of Education and Research (BMBF), Germany | Drug discovery |